Phosphate depletion is the link between growth, stress and diet in the aetiology of MS

Medical Hypotheses

Volumn 63, Issue 2, 2004, Pages 262-267

  Haglin L ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL; PHOSPHATE;

ACCIDENT; ADOLESCENCE; BURN; CLIMATE; DEMYELINATION; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FOOD INTAKE; GROWTH; HUMAN; HYPOPHOSPHATEMIA; HYPOTHESIS; INFECTION; MALNUTRITION; METABOLIC DISORDER; METABOLISM; MODEL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUTRIENT; PHOSPHATE BLOOD LEVEL; PHOSPHATE DEFICIENCY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK; STRESS;

EID: 3242757548     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.11.036     Document Type: Article

References (53)

1. Krüger P.G., Nyland H.I. The role of mast cells and diet in the onset and maintenance of multiple sclerosis: A hypothesis. Med. Hypotheses. 44:1995;66-69
2. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. Update on the epidemiology of multiple sclerosis. Mayo Clin. Proc. 64:1989;808-817
3. Agranoff B.W., Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet. 2:1974;1061-1066
4. Butcher P.J. The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. New Z. Med. J. 83:1976;427-430
5. Butcher P.J. Milk consumption and multiple sclerosis -an etiological hypothesis. Med. Hypotheses. 19:1986;169-178
6. Grønning M., Mellgren S.I. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol. Scand. 72:1985;321-327
7. McAlpine D. The problem of disseminated sclerosis. Brain. 69:1946;233-250
8. Wainerdi H.R. Does the multiple-sclerosis syndrome begin at puberty? BMQ. 1961
9. Hanefeld F, Bauer HJ, Christen H-J, Kruse B, et al. Multiple sclerosis in childhood: report of 15 cases. Brain Dev 1991;13:410-16
10. Alter M., Okihiro M. When is multiple sclerosis acquired? Neurology. 21:1971;1030-1036
11. Adams D.K., Sutherland J.M., Fletcher W.B. Early clinical manifestations of disseminated sclerosis. Br. Med. J. 19:1950;431-436
12. Bamford C.R., Sibley W.A., Thies C., Laguna J.F., et al. Trauma as an etiologic and aggravating factor in multiple sclerosis. Neurology. 31:1981;1229-1234
13. Warren S.A., Warren K.G., Greenhill S., Paterson M. How multiple sclerosis is related to animal illness, stress and diabetes. Can. Med. Assoc. J. 126:1982;377-382. 385
14. Jones H.H., Jones H.H., Bunch L.D. Biochemical studies in multiple sclerosis. Ann. Intern. Med. 33:1950;831-840
15. Bernsohn J., Namajuska I. Phospholipid fractions in multiple sclerosis and normal serum. Proc. Soc. Exp. Biol. 88(4):1995;124-127
16. Horton B.T., Wagener H.P., Aita J.A., Woltman H.W. Treatment of multiple sclerosis by the intravenous administration of histamine. JAMA. 124:1994;800
17. Becker F.O., Michael J.A., Davis F.A. Acute effects of oral phosphate on visual function in multiple sclerosis. Neurology. 24:1974;601-607
18. Bergengren H. Fosforbrist och multiple skleros. En hypotes om sjukdomens etiologi och patogenes. Lk̈artidningen. 61:1964;3515-3551
19. Kurtzke J.F., Dean G., Botha D.P. A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance. S Afr. Med. J. 44:1970;663-669
20. Gall J.C., Hayles A.B., Siekert R.G., Keith H.M. Multiple sclerosis in children. A clinical study of 40 cases with onset in childhood. Pediatrics. 21:1958;703-709
21. Yakovlev P.J. Morphological criteria of growth and maturation of the nervous system in man. Res. Publ. Ass. Res. Nerv. Ment. Dis. 39:1962;3-46
22. Tong X.W., Xue Q.M. Alterations of serum phospholipids in patients with multiple sclerosis. Chin. Med. J. 106:1993;650-654
23. Franklio C.R., Brickner R.M. Vasospasm associated with multiple sclerosis. Arch. Neurol. Psychiatry. 48:1947;125
24. Mc Alpine D., Compston N. Some aspects of the natural history of disseminated sclerosis. QJ Med. 21:1957;135-167
25. Bobowick A.R., Kurtzke J.F., Brody J.A., Hrubec Z. Twin study of multiple sclerosis: an epidemiological inquiry. Neurology. 28:1978;978-987
26. Goldstein J.E., Cogan D.G. Exercise and the optic neuropathy of multiple sclerosis. Arch. Opthalmol. 72:1964;168-170
27. Brickner R., Brill N. Dietetic and related studies in multiple sclerosis. Arch. Neurol. Psychiatry. 41:1941;16-35
28. Kumar A., Ghai O.P., Singh N. Delayed nerve conduction velocities in children with protein-calorie malnutrition. J. Pediatrics. 90:1977;149-153
29. Butcher P.J. Calcium intake and the protein composition of mouse brain: relevance to multiple sclerosis. Med. Hypotheses. 39:1992;275-280
30. Swank R.L., Lerstad O., Strøm A., Backer J. Multiple sclerosis in rural Norway. Its geographical and occupational incidence in relation to nutrition. New Engl. J. Med. 246:1952;721-728
31. Goldberg P. Multiple sclerosis: Vitamin D and calcium as environmental determinants of prevalence. (A viewpoint). Part 1: Sunlight, dietary factors and epidemiology. Int. J. Environ. Stud. 6:1974;19-27
32. Håglin L. The nutrient density of present-day and traditional diets and their health aspects: the Sami- and lumberjack families living in rural areas of Northern Sweden. Int. J. Circumpolar Health. 58:1999;30-43
33. Larsen J.P., Aarli J.A., Nyland H., Riise T. Western Norway, a high-risk area for multiple sclerosis: A prevalence/incidence study in the county of Hordaland. Neurology. 34:1984;1202-1207
34. Alter M., Cendrowski W. Multiple sclerosis and childhood infections. Neurology. 26:1976;201-204
35. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. New Engl. J. Med. 343:2000;938-952
36. Håglin L., Burman L.Å., Nilsson M. High prevalence of hypophosphataemia amongst patients with infectious diseases. A retrospective study. J. Intern. Med. 246:1999;45-52
37. Hutter C. On the causes of multiple sclerosis. Med. Hypotheses. 41:1993;93-96
38. Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Part 2. Biochemical and genetic factors. Int. J. Environ. Stud. 6:1974;121-129
39. Miller D.W., Slovis C.M. Hypophosphatemia in the emergency department therapeutics. Am. J. Emerg. Med. 18:2000;457-461
40. Dale G., Fleetwood J.A., Inkster J.S., Sainsbury J.R.C. Profound hypophosphataemia in patients collapsing after a fun run. Br. Med. J. 292:1986;447-448
41. Lovén L., Larsson L., Lindell B., Sjöberg H.E., et al. Effect of propranolol on post-traumatic hypophosphataemia and catecholamine secretion. Acta Clin. Scand. 151:1985;201-204
42. Zazzo J.-.F., TrochéG, Ruel P., Maintenant J. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med. 21:1995;826-831
43. Lovén L., Jansson I., Larsson L., Lennquist S. Posttraumatic hypophosphataemia and urinary phosphate excretion with and without phosphate supplementation. An experimental study in pigs. Acta Chir. Scand. 149:1983;233-238
44. Huszák J., Széchenyi The disturbance of the metabolism of keto-bodies in multiple sclerosis. Brain. 69:1946;427-436
45. Backmund H., Gerlinghoff M. Anorexia nervosa. Bedrohliche neurologische Komplikationen durch Hypophosphatämie [Anorexia nervosa. Severe neurologic complications caused by hypophosphataemia]. Nervenarzt. 57:1986;542-544
46. Håglin L. Hypophosphataemia in anorexia nervosa. Postgrad. Med. J. 77:2001;305-311
47. Brautbar N., Massry S.G. The myopathy of phosphate depletion. Adv. Exp. Med. Biol. 178:1984;363-375
48. Boskey A.L., Gilder H., Neufeld E., Ecarot B., et al. Phospholipid changes in the bones of the hypophosphatemic mouse. Bone. 12:1991;345-351
49. Adams C.W. Pathology of multiple sclerosis: progression of the lesion. Br. Med. Bull. 33:1977;15-20
50. Chudley A.E., Ninan A., Young G.B. Neurologic signs and hypophosphatemia with total parenteral nutrition. Can. Med. Assoc. J. 125:1981;604-607
51. Knochel J.P. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch. Intern. Med. 137:1977;203-220
52. Backmund H., Mai N., Gerlinghoff M. Life-threatening complications and death in anorexia nervosa. Schweiz. Arch. Neurol. Psychiatry. 141:1990;419-428
53. Barbe B., Lejoyeux M., Bouleau J.H., Petitjean F., et al. Visual hallucination related to severe hypophosphataemia. Lancet. 338:1991;1083